Get in touch
Have a question, or want a product recommendation?
Cannabinoids, as a group, have had an uncertain legal status for a number of years. This is rapidly changing, however. On December 20, 2018, the Agriculture Improvement Act of 2018 (2018 Farm Bill, PL 115-334) was signed into law federally. The legal definition of hemp is the Cannabis sativa L. plant with a THC concentration of less than 0.3 percent, by dry weight. Anything above 0.3 percent THC is essentially classified as "marijuana" and is federally illegal, although some states have legalized all forms of cannabis.
In the United States, we are governed by local, state and federal laws. These laws, and their practical enforcement, may vary from state to state and municipality to municipality. There may be situations where local agencies have not updated their laws to remove CBD from their ban of Schedule 1 drugs to date. With the demand of cannabis-based products growing globally, it appears to simply be a matter of time before laws are updated nationwide, allowing for significantly decreased restrictions around cannabinoid consumption. If you are concerned about the legality of a cannabinoid product you are considering, we recommend that you ask for a Certificate of Analysis to be sure you know what you are getting and consult with your medical provider before consuming any product.
The Formula30A product line is only sold through licensed medical professionals. You will not find any of our products sold through eBay, Amazon, or any other retail outlets, as we believe that patient education on endocannabinoid system, and how full-spectrum extracts interact with this system, are vital. This includes how cannabinoid consumption may interact with some prescription drugs or other medical conditions that can affect treatment plans.
As a result, Formula30A only allows patients to purchase cannabinoid products through Formula30A-approved, licensed medical professionals. Registered healthcare providers who opt in to online ordering can provide their patients with their Formula30A Provider Link, allowing patients to place orders online for drop shipping.
If your medical provider isn’t currently carrying Formula30A or has not yet investigated the endocannabinoid system in depth, please reach out to us so we can refer you to a certified Formula30A provider. If your current provider would be interested in learning more about the endocannabinoid system and carrying cannabinoid products for their patients, please refer your provider to us for more information.
Formula30A only distributes through licensed healthcare providers. However, healthcare providers who are unable to prescribe other forms of medication are not restricted from carrying Formula30A cannabinoids. Most licensed healthcare professionals will qualify to carry and provide Formula30A products to their patients.
Examples of practitioners we work with include, but are not limited to:
Doctor of Medicine (M.D.); Doctor of Osteopathic Medicine (D.O.); Registered Nurse (R.N.); Nurse Practitioner (N.P.); Advanced Practice Nurse Practitioner (A.P.N.P./A.P.N.); Advanced Practice Registered Nurse (A.P.R.N./A.P.R.); Certified Nurse-Midwife (C.N.M.); Certified Nurse Practitioner (C.N.P./N.P.-C./N.P.B.C.); Certified Registered Nurse Anesthetist (C.R.N.A.); Doctor of Nursing Practice (D.N.P.); Licensed Practical Nurse (L.P.N.); Physician Assistant (P.A.); Certified Physician Assistant (P.A.-C.).
Don't see your specialty above? Feel free to send us a quick message to check your eligibility.
Formula30A cannabinoids are created using full-spectrum hemp extract. In addition to key components such as CBD or CBG, there are over 100 other naturally occurring compounds present in our products, including trace amounts of THC (less than 0.3% by dry weight, as determined by US law). Just like consuming poppy seeds may lead to a positive drug test for opioids, the consumption of hemp products may lead to a positive drug test for THC.
That is why Formula30A advises patients to purchase their cannabinoids from a licensed Medical Provider who can provide you and your employer with the necessary paperwork verifying Formula30A products contain less than the legal limit of 0.3 percent THC. Additionally, our Formula30A Cannabigerol (CBG) product lines contain zero THC from seed to shelf. Our Medical Advisory board recommends that you reach out to your Human Resources department or your employer with a letter from your provider and a copy of the Certificate of Analysis of Formula30A before consuming any cannabis-derived product. Once you have your approval, then you can enjoy the benefits of Formula30A without the risk.
Employers commonly use standard urine tests to identify illicit substances in the urine. As most of these types of tests are geared towards identifying THC, rather than CBD or other cannabinoids, trace amounts of THC in legal full spectrum cannabinoid products may register as a failed drug test. More accurate tests, such as blood tests that can measure THC from hemp versus THC from marijuana, can help to prevent false positives where available.
If you are consuming any cannabis product that claims to be THC-free or Isolate, it is strongly recommended that you consult with your physician. According to a 2020 study performed by the FDA, 45% of CBD products tested contained the amount of CBD advertised (within ±20%). Even more worrying, 49% of products test had THC levels that exceeded the legal limit for hemp extracts. We recommend that you always ask for a certificate of analysis and confer with your medical provider before consuming any cannabinoid product.
Hemp (the legal term for the Cannabis sativa plant with less than 0.3% THC content by dry weight) has over 100+ phytocannabinoids of which CBD, CBC, CBG CBN and THC are just to name a few that have been identified and studied. There are additional naturally occurring compounds called terpenes and flavonoids which are believed to have therapeutic effects in full spectrum extracts.
During extraction for Full Spectrum hemp oil, the whole plant flower is used, maintaining the plant's balance of cannabinoids, terpenes, and flavonoids. According to studies from Israeli biochemist Dr. Raphael Mechoulam, who has studied the endocannabinoid system throughout his career, the whole plant creates an “entourage effect” in the body, with greater efficacy when all the parts of the plant are maintained during the extraction process of the oil.
On the other hand, the Isolate extraction process attempts to remove all these phytocannabinoids, flavonoids, terpenes and isolate only the cannabidiol compound (CBD) into what is defined as a CBD isolate. In a study done by researchers in 2015 in Israel, they found that the single-molecule CBD administration created a bell-shaped-dose-response curve with a narrow therapeutic window. These studies showed that when CBD exceeded a certain point its therapeutic impact declined dramatically. This is not the case with full spectrum hemp extract, as the compounds work synergistically together to create the anti-inflammatory response desired.